Dr Joakim Crona provides an overview of practice changing clinical trials within the field of neuroendocrine tumours and neuroendocrine carcinomas
Endocrinology Oncology Rare diseases
Practice changing clinical trials in NET
Publication Date
Nov 2019
Joakim Crona is a resident in clinical oncology and associate professor in molecular oncology at Uppsala Academic Hospital, Sweden. He’s had a particular interest for neuroendocrine tumors since more than eight years. This included successfully defending his thesis covering genetics of neuroendocrine tumors, as well as working as a physician at the clinic of endocrine oncology. Joakim has just returned from a short term fellowship at the Pheochromocytoma/Paraganglioma Program, US National Institutes of Health. He plans a future career in the field of endocrine oncology that will unite clinical science with molecular biology, aiming at improving treatment of patients with these rare diseases.
Dr Joakim Crona has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Novartis.
DOWNLOAD SLIDES 
Programme summary
Duration 5 MIN- Downloadable resources Yes
-
DOWNLOAD SLIDES
-
Language(s)
Duration 
Language(s)
Share this programme
Brought to you by
NET CONNECT is an initiative of COR2ED, supported by Independent Medical Educational Grants from Ipsen and from Eisai Europe Limited.
Meet the expertsOther programmes of interest
Other
Oncology
The evolving role of liquid biopsy in biomarker testing
Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer
Experts
Assoc. Prof. Umberto Malapelle-
Downloadable
Resources -
5 MIN
-
Jul 2024
Downloadable 
5 MIN
Jul 2024 
Interactive patient case
Oncology
Advanced renal cell carcinoma: Managing a long-term durable response
Maximising outcomes for patients with advanced RCC
Experts
Prof. Michael StaehlerEndorsed by
-
15 MIN
-
Jun 2024
Other
Episode
1
of 1
Oncology
Overcoming pre-analytical phase challenges in gastric, prostate and lung cancer
Medical experts make recommendations for best practice
Experts
Dr Alexander Wyatt, Prof. Frédéric BibeauEndorsed by
-
Downloadable
Resources -
5 MIN
-
Jun 2024
Conference update
Oncology
Oncogene-addicted NSCLC: Highlights from ASCO 2024
The latest non-small cell lung cancer data presented at ASCO
Experts
Prof. Nicolas Girard-
Downloadable
Resources -
3 MIN
-
Jun 2024
Conference update
Oncology
Upper and lower GI cancer update from ASCO 2024
GI oncologists review the latest data presented at ASCO 2024
Experts
Dr Samuel J Klempner, Dr Elizabeth Smyth, Prof. Jenny Seligmann, Dr Dominik Modest-
8 MIN
-
Jun 2024
Oncology Hemato-oncology
Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)
Medical experts discuss the latest learnings from clinical practice
Experts
Prof. Aurore Perrot, Prof. Hermann Einsele, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter-
Downloadable
Resources -
76 MIN
-
Jun 2024
